Abstract
After an ischemic injury, the heart undergoes a complex process of structural and functional remodeling that involves several steps, including inflammatory and fibrotic responses. In this review, we are focusing on the contribution of microRNAs in the regulation of inflammation and fibrosis after myocardial infarction. We summarize the most updated studies exploring the interactions between microRNAs and key regulators of inflammation and fibroblast activation and we discuss the recent discoveries, including clinical applications, in these rapidly advancing fields.
Original language | English (US) |
---|---|
Article number | 863238 |
Journal | Frontiers in Cardiovascular Medicine |
Volume | 9 |
DOIs | |
State | Published - Apr 13 2022 |
Keywords
- cardiac remodeling
- clinical trials
- drug development
- epigenetics
- heart failure
- ischemic heart disease
- non-coding RNA
- oxidative stress
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine